Rubella IgG Serology
Within scope of accreditation
Determining immunity to Rubella
PURPOSE OF PROGRAMME:
To provide EQA for laboratories determining immunity to rubella. (Determining immunity to the rubella virus was one of the recommended ante natal screening tests until April 2016. The success of the vaccination programme has resulted in the disease being incredibly rare in the UK and is now classified as eliminated according to World Health Organization criteria. The scheme remains live until routine screening has been phased out. Diagnostic testing will continue to be covered – see Parvovirus and Rubella IgG and IgM.)
PROGRAMME OF ANALYSIS:
Results are entered online via the UK NEQAS secure website. The distribution is open for three weeks. Intended results are usually uploaded the day after closing date. Late results are not accepted after intended results are uploaded.
Qualitative detection, consensus. General descriptive statistics.
PERSISTENT POOR PERFORMANCE:
See the Annual Directory for UK and Irish participants only
The first distribution of UK NEQAS for Microbiology was sent out by the then Public Health Laboratory Services on the 1st of May 1971 organised by Dr Peter Crone. This distribution consisted of one scheme, three bacteriology specimens, sent to 67 laboratories in the UK. One of our recent distributions consisted of 12 different schemes, comprising 8 bacteriology, 13 serology, 10 molecular and 9 mycology specimens, and sent to 53 countries representing over 1300 laboratories. UK NEQAS for Microbiology, operated by Public Health England, is a UKAS accredited proficiency testing provider No. 4715.